Mikael Dolsten
Direktor/Vorstandsmitglied bei
ROCKET PHARMACEUTICALS, INC.
Vermögen: 966 361 $ am 30.06.2026
Profil
Mikael Dolsten hat die Position des Chief Scientific Officer & Research President bei Pfizer Inc. inne. Dr. Dolsten ist auch im Vorstand der New York Academy of Sciences, Karyopharm Therapeutics, Inc. und der PhRMA Foundation sowie Mitglied der Royal Swedish Academy of Engineering Sciences und Mitglied des Government-University-Industry Research Roundtable. In der Vergangenheit war er Principal bei OrbiMed Advisors LLC und Partner bei OrbiMed Advisors Private Equity (einer Tochtergesellschaft von OrbiMed Advisors LLC), Präsident für Wyeth Research, EVP, Global Head-Pharma Research & Discovery bei Boehringer Ingelheim Pharmaceuticals, Inc. und Senior Vice President bei Wyeth Corp. sowie Mitglied des Ausschusses für Leistungen, Recht und Regulierung bei Wyeth Pharmaceuticals LLC. Dr. Dolsten erhielt einen Doktortitel von der Universität Lund.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.05.2026 | 5 548 ( 0 % ) | 736 941 $ | 30.06.2026 | |
| 18.06.2026 | 67 082 ( 0,06 % ) | 229 420 $ | 30.06.2026 |
Aktuelle Nachrichten zu Mikael Dolsten
Aktive Positionen von Mikael Dolsten
| Unternehmen | Position | Beginn |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 21.09.2021 |
| ROCKET PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 09.09.2024 |
| SWEDISH ORPHAN BIOVITRUM AB | Direktor/Vorstandsmitglied | 06.05.2026 |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services Operates engineering science academy | Corporate Officer/Principal | - |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Direktor/Vorstandsmitglied | - |
Orbis Medicines ApS
 Orbis Medicines ApS Internet Software/ServicesTechnology Services Operates as a novel macrocyclic chemistry and computational platform for drug discovery | Vorsitzender | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Direktor/Vorstandsmitglied | - |
Government-University-Industry Research Roundtable
 Government-University-Industry Research Roundtable Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mikael Dolsten
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Mikael Dolsten
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
24
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 24 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Engages in the advancing science, technology and society worldwide services for charity | Commercial Services |
New York Hall of Science
 New York Hall of Science Other Consumer ServicesConsumer Services Operates as a center for interactive science | Consumer Services |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Commercial Services |
Research!America
Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Commercial Services |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services Operates engineering science academy | Commercial Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Government-University-Industry Research Roundtable
Government-University-Industry Research Roundtable Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Vimian Group AB
 Vimian Group AB BiotechnologyHealth Technology Operates as a animal health company | Health Technology |
Orbis Medicines ApS
Orbis Medicines ApS Internet Software/ServicesTechnology Services Operates as a novel macrocyclic chemistry and computational platform for drug discovery | Technology Services |
